Morgan Stanley Lucid Diagnostics Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Morgan Stanley holds 394 shares of LUCD stock, worth $394. This represents 0.0% of its overall portfolio holdings.

Number of Shares

394

Previous 954 58.7%

Holding current value

$394

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.75 - $0.88 $420 - $492	-560 Reduced 58.7%	394 $0
Q2 2024 Oct 17, 2024	SELL	$0.67 - $1.04 $14 - $22	-22 Reduced 2.25%	954 $0
Q2 2024 Aug 14, 2024	SELL	$0.67 - $1.04 $14 - $22	-22 Reduced 2.25%	954 $0
Q1 2024 Oct 17, 2024	BUY	$0.81 - $1.52 $17 - $33	22 Added 2.31%	976 $0
Q1 2024 Aug 16, 2024	BUY	$0.81 - $1.52 $628 - $1,179	776 Added 388.0%	976 $0
Q1 2024 May 15, 2024	BUY	$0.81 - $1.52 $628 - $1,179	776 Added 388.0%	976 $0
Q4 2023 Aug 16, 2024	SELL	$1.16 - $1.54 $874 - $1,161	-754 Reduced 79.04%	200 $0
Q2 2023 Aug 14, 2023	SELL	$1.28 - $1.78 $768 - $1,068	-600 Reduced 75.0%	200 $0
Q1 2023 May 15, 2023	SELL	$1.17 - $1.77 $108 - $164	-93 Reduced 10.41%	800 $1,000
Q4 2022 Feb 14, 2023	SELL	$1.21 - $2.27 $22,216 - $41,679	-18,361 Reduced 95.36%	893 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.53 - $3.45 $59,810 - $134,867	-39,092 Reduced 67.0%	19,254 $30,000
Q2 2022 Oct 27, 2022	BUY	$1.73 - $3.44 $84,972 - $168,962	49,117 Added 532.2%	58,346 $131,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $3.44 $84,972 - $168,962	49,117 Added 532.2%	58,346 $131,000
Q1 2022 Oct 27, 2022	SELL	$2.85 - $5.24 $139,983 - $257,373	-49,117 Reduced 84.18%	9,229 $31,000
Q1 2022 May 13, 2022	SELL	$2.85 - $5.24 $35,719 - $65,672	-12,533 Reduced 57.59%	9,229 $31,000
Q4 2021 Feb 14, 2022	BUY	$4.87 - $11.76 $105,980 - $255,921	21,762 New	21,762 $116,000

Others Institutions Holding LUCD

# of Institutions

Shares Held

2.54M

Call Options Held

Put Options Held

View Full List

About Lucid Diagnostics Inc.

Ticker LUCD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 38,568,500
Market Cap $38.6M
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...

More about LUCD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account